Results 91 to 100 of about 29,864 (215)

Intravenous thrombolysis for acute stroke.

open access: yesCleveland Clinic Journal of Medicine, 2004
Intravenous t-PA is effective if given to appropriate patients within 3 hours of stroke onset, and its effectiveness increases even within the first 3 hours when given as soon as possible. t-PA is reasonably safe if used in a carefully defined manner that ensures close attention to blood pressure, careful patient monitoring, no use of heparin and ...
openaire   +2 more sources

Study on the efficacy and safety of aspirin combined with clopidogrel pretreatment before rt⁃PA intravenous thrombolysis in patients with cardioembolism

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2020
Objective To investigate the efficacy and safety of aspirin combined with clopidogrel pretreatment before intravenous thrombolysis with rt ⁃ PA in patients with cardioembolism (CE). Methods Three hundred and thirteen patients with CE treated with rt ⁃ PA
Chen⁃hua LI   +5 more
doaj  

A Rare Constellation of Peripartum Cardiomyopathy Manifesting With Multiple Thromboembolic Phenomena in a 15‐Year‐Old

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 15‐year‐old postpartum primipara presented at 19 days with aphasia, right hemiparesis, chest pain, and dyspnea. Diagnostics confirmed concurrent cardioembolic stroke and pulmonary embolism secondary to peripartum cardiomyopathy (ejection fraction 29%).
Reuben E. Mkama   +39 more
wiley   +1 more source

Analysis of risk factors for early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke

open access: yesFrontiers in Neurology
ObjectiveThe aim of this study is to examine the potential risk factors contributing to early neurological deterioration (END) following intravenous thrombolysis in patients diagnosed with acute ischemic stroke (AIS).MethodsClinical data was gathered ...
Jungang Fang, Hui Sun, Xinyu Lu
doaj   +1 more source

The Association between Hypoperfused Myocardium and Systolic Function in Patients With AMI Undergoing Complete Revascularization

open access: yesClinical Cardiology, Volume 49, Issue 8, August 2026.
Hypoperfused myocardium was detected in portions of acute myocardial infarction patients undergoing complete revascularization by hybrid positron emission tomography/magnetic resonance at 2 months. Patients with hypoperfused myocardium (Group A) had higher hs‐CRP and lower T2 values than those without (Group B). The reversal of myocardial perfusion was
Jin Si   +11 more
wiley   +1 more source

Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis

open access: yesThe Egyptian Journal of Internal Medicine
Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h.
Lisda Amalia, Putri Qonitah
doaj   +1 more source

Predictors and a Nomogram for Parenchymal Hematoma After Endovascular Thrombectomy in Large Core Ischemic Stroke

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 8, August 2026.
This study developed and internally validated a nomogram incorporating baseline NIHSS score, monocytes, platelets, post‐thrombectomy fasting blood glucose, and number of passes to predict parenchymal hematoma after EVT in large core infarctions. A pass‐by‐IVT interaction suggests minimizing unnecessary passes during direct thrombectomy.
Jiamin Li   +9 more
wiley   +1 more source

Machine Learning Methods to Predict the Length of Stay for Acute Stroke: A Scoping Review and Meta‐Analysis

open access: yesHealth Care Science, Volume 5, Issue 4, Page 376-387, August 2026.
Current machine learning models for predicting the length of stay for acute stroke lack clinical utility and reliability. This scoping review highlights areas for improvement to develop more robust, interpretable, generalizable, and clinically actionable models that optimize personalized clinical pathways and support precise decision‐making for stroke ...
Zhenran Xu   +4 more
wiley   +1 more source

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Ischemic stroke remains a leading cause of death and disability worldwide, and bleeding (particularly intracranial hemorrhage) continues to limit conventional antithrombotic therapy in secondary prevention, even with direct oral anticoagulants.
Federica Ferrari, Roberto Federico Villa
wiley   +1 more source

Microfluidic Production of Antibacterial Alginate (Alg‐PEI/AgNP) Microbubble‐Templated Scaffolds for Biomedical Applications: Controlled Pore Architecture and Sustained Silver Release

open access: yesMacromolecular Materials and Engineering, Volume 311, Issue 8, August 2026.
Antibacterial porous microbubble‐templated scaffolds are created using a T‐junction microfluidic system to template alginate‐polyethyleneimine microbubbles loaded with silver nanoparticles. These scaffolds have tunable pore sizes, can hold over 3600% water, and demonstrate sustained silver release for up to 168 h.
Fatih Eroglu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy